D, is a low-molecular-weight cyclic siloxane used for industrial and consumer product applications. The objective of the present study was to assess potential toxic and immunomodulatory consequences of inhalation exposure to D 5 . Male and female Fischer 344 rats (25/group) were exposed by whole body inhalation to 0, 10, 25, 75, or 160 ppm D 5 6 h/day, 7 days/week for 28 days. Clinical signs, body weights, and food consumption were recorded. On the day following the final exposure, 10 rats/group/sex were euthanized and a complete necropsy performed. Following a 14-day nonexposure recovery period, the remaining 5 rats/sex/group were necropsied. Body and organ weights were obtained and a complete set of tissues was taken for histopathology. Samples were also collected for serum chemistry, hematology, and urinalysis. Immunotoxicology-designated rats (10/sex/group) were immunized with sheep erythrocytes (sRBC) 4 days prior to euthanasia and cyclophosphamide (CYP) was administered i.p. to positive controls on days 24 through 28. The anti-sRBC antibody-forming cell (AFC) response was evaluated in a standard plaque assay. Blood was also collected for examination in the anti-sRBC enzyme-linked immunosorbant assay (ELISA). D 5 exposure did not modulate humoral immunity, while the internal control, CYP, produced the expected suppression of the AFC response. D 5 exposure caused no adverse effects on body weight, food consumption, or urinalysis parameters. Serum alkaline phosphatase (SAP) was significantly decreased in females at terminal (12%, 160 ppm) and recovery sacrifice. A significant increase in the liver-to-body weight ratio was observed in female animals at the end of exposures (13%, 160 ppm), but was not noted in recovery animals from the same exposure group. In males, significant increases in liverto-body weight (5%) and thymus-to-body weight (14%) ratios were also noted at the high dose at terminal sacrifice and were not present at recovery. At recovery only, a significant increase in spleen-to-body weight ratios (14 and 17%; 25 and 160 ppm, respectively) was noted. At the end of exposure, histopathological
analysis indicated an increased incidence and severity of nasal (Level 1) goblet cell proliferation. Focal macrophage accumulation in the lung was also observed to be increased in incidence in both sexes at 160 ppm. At the end of the recovery period, the effects in both of these organs appeared to be reversible. In summary, D 5 inhalation exposure did not alter humoral immunity and caused only minor, transient changes in hematological, serum chemistry, and organ weight values. Histopathological changes were confined to the respiratory tract and appeared to be reversible. The no observed effect level for systemic toxicity, based primarily on the liver weight changes, was 75 ppm. o IWS sod«y of Toxicology.
Silicones may be broadly defined as synthetic chemical materials which have measurable viscosity and contain a diorganosiloxy repeat unit [(R 2 SiO) n ]. They consist of fluids, gels, elastomers, and resins, each with physical characteristics which make them desirable for a variety of commercial applications including industrial, medical, military, and consumer uses. Decamethylcyclopentasiloxane (D 5 ) is a clear, odorless, synthetically derived silicone fluid with a molecular weight of 370. Chemically, D 5 consists of alternating silicon-oxygen bonds connected in a ring (cyclic) arrangement with two methyl groups covalently bonded to each silicon atom (MejSiO^. It is a member of a family of low-molecular-weight cyclic siloxanes whose hydrophobic and low surface energy properties provide a unique basis for some of its selected uses. D 5 is used primarily in consumer product applications (personal care products) such as antiperspirants and shampoos.
Although the dimethylsilicone fluids (as well as other silicones) have been reported to be safe, in recent years interest has focused on he biocompatibility of silicones and the potential for these materials to produce immunomodulatory effects. This has largely been driven by the clinical literature containing reports of adverse reactions to silicone-containing medical materials (e.g., lubricants in tubing and syringes and in numerous implantable devices). Despite the fact that there has been persistent speculation that silicone-containing medical devices may provoke or exacerbate systemic immune disease, no link between exposure to silicones and human disease has been established. Previous studies have demonstrated that D 5 and its chemical analog D 4 , when administered via vapor inhalation cause an increase in liver weight (McKim et al, 1995; Additionally, both D 4 and D s , as well as lanolin, isopropyl palmitate, and white mineral oil (other materials found in personal care products), have demonstrated humoral adjuvancy potential when administered intramuscularly to rats in conjunction with bovine serum albumin (Klykken and White, 1996) . In both cases, the magnitude of the increase appeared to be related to decreasing molecular size.
The objective of the present studies was to gain insight regarding the immunomodulatory potential of D 5 following a 28-day whole body inhalation exposure in the rat. These studies were designed to allow investigation of the immunomodulatory potential of D 5 in conjunction with increases in liver weight. Although the primary route of exposure to D 5 for the consumer is dermal, the physical properties of D 5 preclude using dermal application of the neat material as a route of exposure to assess potential immunological hazard. Inhalation is the primary route of exposure in the occupational setting and there is an inhalation component following the use of D 5 in consumer products. This study, one in a series examining the safety of a family of cyclic siloxane materials (e.g., D 4 -D 6 ), was designed to be comparable with a previously conducted study on D 4 (Klykken et al) , a material whose use and exposure is similar to that of D 5 . Target exposure concentrations (0, 10, 25, and 75 ppm) were chosen so that an equimolar comparison (based on target test atmospheres) with D 4 could be made. In addition, 160 ppm was chosen as the high concentration because in method development studies optimizing exposure conditions (including vapor concentration and chamber/room temperature) for this experiment, it was the greatest achievable and reproducible concentration which contained no aerosol. The splenic antibody-forming cell (AFC) response to sheep erythrocytes (sRBC) was chosen as the system to investigate immune status of exposed rats because it is a sensitive indicator of immunocompetence, requiring the coordinated interactions of several immune cells. In addition, a traditional toxicological assessment (body weights, food consumption, organ weights, pathology, clinical chemistry, etc.) was conducted.
MATERIALS AND METHODS
Animal housing and maintenance. Male and female Fischer 344 rats were obtained from the Charles River Breeding Laboratories (Kingston, NY) at 4-5 weeks of age. Upon arrival at WIL Research Laboratories, Inc. (Ashland, OH), all rats were placed in quarantine for a period of 1 week. Animals were housed individually in suspended stainless steel, wire mesh-bottom cages where they had access to certified rodent chow (Purina 50O2C) and water ad libitum. Animals were computer-assigned by weight stratification to study groups using the WIL toxicology data management system (WTDMS). Rats were allowed a 1-week pretest period where body weights and food consumption were measured. Throughout the in-life phase of the study animals were housed in a facility designed to maintain appropriate environmental conditions (12 h light/dark cycle, 65-78°F, 40-70% humidity, 10-15 air changes/h).
Test and control materials. D 5 was obtained from Dow Corning Corporation (Midland, MY) and was determined to be >99% D 5 (Lot BxWCO 15338). Purity and composition of the test material were confirmed by GC/MS analysis. Cyclophosphamide (CYP) was prepared at 5 mg/ml in PBS and frozen until used in the study. Animals received i.p. injections of 0.005 rruVg of body weight.
Experimental system. All animals were exposed 6 h/day, 7 days/week for 28 days to either D 3 vapor (target concentrations of 10, 25, 75, and 160 ppm) or room air. Ten rats/sex/group were euthanized 1 day after the final exposure (terminal necropsy). Following a 14-day period of non-exposure (recovery) the remaining 5/sex/group were euthanized. Five rats/sex served as immunosuppressive controls for the AFC assay and received CYP on days 24 through 28, prior to exposure periods. Clinical observations of all animals were made twice daily. Body weights were measured twice weekly and food consumption was measured weekly.
Inhalation exposures.
Exposures to D 3 vapor were conducted in four 1.0 m 3 and one 2.0 m 3 (controls) stainless-steel and glass inhalation chambers operated under dynamic conditions. Airflow in all chambers was kept at approximately 12-15 changes/h. Mass airflow, temperature, relative humidity, chamber negative pressure, and oxygen content were continually monitored and recorded every 30 min. D 5 vapor was generated using a glass J-tube method and the concentration of D 5 in each chamber was measured at least once an hour using a Hewlett-Packard 5890 Series II GC. The GC was calibrated daily prior to each exposure period. Mean chamber concentrations were calculated to determine an average exposure concentration and that value was compared to the targeted D 5 concentrations. The high concentration of 160 ppm was chosen because in method development studies optimizing exposure conditions (including vapor concentration and chamber/room temperature) for this experiment, it was the highest achievable, reproducible concentration which contained no aerosol.
Hematology and serum chemistry. Blood was collected from the vena cava or by cardiac puncture for hematology and serum chemistry measurements. Hematology endpoints included RBC count, hemoglobin, hematocrit, MCV, MCHC, MCH, platelet count, reticulocyte count, and both total and differential leukocyte count, prothrombin time, and activated partial thromboplastin time. Serum chemistry measurements included phosphorus, calcium, chloride, potassium, sodium, glucose, serum alkaline phosphatase (SAP), blood urea nitrogen (BUN), aspartate amino transferase (AST), alanine amino transferase (ALT), lactate dehydrogenase (LDH), gamma glutamyl transaminase (-y-GT), total bilirubin, direct bilirubin, indirect bilirubin, total cholesterol, triglycerides, creatinine, uric acid, total protein, albumin (A), globulin (G), and A/G ratio.
Urinatysis. The afternoon preceding euthanasia, animals designated for general toxicological endpoints were transferred into stainless steel metabolism caging which allow for collection of urine and were fasted. Water was provided ad libitum. Urinalysis was performed and included specific gravity, pH, ketones, bilirubin, protein, glucose, occult blood, urobilinogen, and microscopic examination of the sediment.
Pathology. A complete gross necropsy was performed on all general toxicology animals. Organ weights were obtained on liver, spleen, testes, heart, lung, thymus, ovaries, kidneys, adrenals, and brain. A complete set of tissues was collected for histopathology. Following collection, tissues were placed directly into 10% neutral-buffered formalin for fixation. The eyes were fixed in Davidson's fixative overnight and then transferred to \0% buffered formalin. Collected tissues were processed, embedded in paraffin, sectioned, and stained with hematoxylin and eosin using standard histological methods. Nasal cavities were prepared, following decalcification, according to the method of Young (1981) . All prepared tissue slides were examined by a board-certified veterinary pathologist using light microscopy. " Animals (n = 10/sex/group) were exposed by whole body inhalation for 28 days (6 h/day, 7 days/week) to the indicated concentrations of D 3 vapor. Animals were euthanized on Day 29 after initiation of exposures. Data are presented as the mean ± SD.
• Statistically significant from control (0 ppm) at p ^ 0.05 as determined by Dunnett's test. ** Statistically significant from control (0 ppm) at p £ 0.01 as determined by Dunnett's test.
The hemolylic plaque assay and serum anti-sRBC ELISA. sRBC were received from the Medical College of Virginia (MCV), washed, and resuspended to 2 X 10 s sRBC/ml in a balanced salt solution. Rats were immunized intravenously (i.v.) with 1 ml of prepared sRBC approximately 96 h prior to spleen harvest. The route of antigen exposure was chosen to correspond with the current draft version of the recently finalized EPA TSCA (OPPTS) 40 CFR Part 799.9780 Immunotoxicity Testing Guideline. In addition, it is the most often used and the most well-characterized route of antigen administration when assessing the systemic immune effects of xenobiotics. At the time of euthanasia, blood was collected and sera prepared and stored for ELISA determinations. Immunized animals were euthanized with CO 2 . Spleens were removed, weighed, and placed into individual tubes containing BSS supplemented with HEPES buffer. Spleen tubes were placed on ice and hand-carried to MCV. The AFC assay was performed using a standard hemolytic plaque assay within 24 h of spleen harvest (Jerne and Nordin, 1963; Holsapple et al., 1984; McCay and Woolhiser, 1995) . Additionally, the anti-sRBC ELISA (Temple et al., 1993 (Temple et al., , 1995 was performed at MCV on the serum samples collected at the time of euthanasia. Briefly, sRBC membranes were bound to microtiter plates by incubation overnight at 4°C. Prior to each subsequent step, plates were washed three times with 0.01 % Tween 20 in water using a BioTek automated plate washer. Nonspecific sites were blocked with 0.05% Tween 20 in PBS, pH 7.4, for 1 h. Ten twofold serial dilutions of sera were then added in duplicate to wells and incubated for 1 h at room temperature. The secondary antibody, HRP-conjugated anti-rat IgM, was added and allowed to sit at room temperature for 1 h. Color was developed using peroxidase substrate and read after a 45-min development period at 405 nm using a Molecular Devices Thermo MM microtiter plate reader.
Statistical analysis. The AFC assay and ELISA data were tested for homogeneity of variances using the Bartlett's x 2 test (Bartlett, 1937) . Homogeneous data were evaluated by a parametric one-way ANOVA. Nonhomogeneous data were evaluated using a nonparametric ANOVA. The Jonckheere test (Jonckheere, 1955) was used to test for exposure-related trends across exposure levels. Responses from CYP-exposed animals were compared to the room air control group using a Student t test. Statistical significance was evaluated atp £ 0.05. All other general toxicology parameters were evaluated using Dunnett's test (Dunnett, 1955) to determine significant differences between test and control groups.
RESULTS
Exposure conditions. At each target exposure level (0, 10, 25, 75, and 160 ppm), analytical values for test atmosphere concentrations were obtained daily for each exposure. During exposures, mean D 5 chamber concentrations measured were 10 ± 0.3, 25 ± 0.5, 75 ± 1.1, and 160 ± 4.0 ppm. For the exposure period, mean temperature ranged between 22.2 and 23.3°C, mean relative humidity ranged between 46.5 and 53.3%, and mean O 2 concentration between 20.7 and 20.9%.
Animal observations. Animals were examined daily for signs of any D 5 -related toxicity. Throughout the study, rats (including controls) increasingly displayed ocular opacity, which may be nonspecifically related to prolonged exposure to any vapor or to a genetic predisposition of these animals to this condition. Additional clinical signs included dried red material staining around the eyes and nose and urine staining of the fur. These observations were random and not concentrated within any one exposure group.
Body and organ weights/food consumption. Body weights were measured twice weekly and food consumption was monitored once weekly throughout the in-life phase of the study. Both male and female rats exposed by whole body inhalation to D 5 exhibited normal weight gain over the course of the study (data not shown). In addition, there were no differences in food consumption between D 5 or control groups throughout the investigation (data not shown).
In male rats, there was a statistically significant increase in lung weight (15%) in the 160 ppm group at the end of 28 days of exposure (Table 1) . There was also a slight (4%) increase in male liver weight. When expressed as a percentage of final FIG. 1. Liver to body weight ratios in male (top) and female (bottom) rats following inhalation exposure to D 3 . Fisher 344 rats were exposed by whole body inhalation (6 h/day, 7 days/week) for 28 days to the indicated concentrations of D 3 vapor. Animals were euthanized on Day 29 after initiation of exposures (terminal) or following a 14-day period of nonexposure (recovery). Data represent the mean liver to body weight ratio for 10 animals/group (terminal) or 5 animals/group (recovery). The data are calculated as grams of liver weight per 100 g of final body weight. **Significantly different from room air control at P £ 0.01 as determined by Dunnett's test. body weight (organ weight/100 gm final body weight), this increase was statistically significant (Fig. 1) . In female rats, the increase in liver weight was statistically significant at 160 ppm (15%) and appeared to be exposure-related (Table 1) , suggesting that female rats may be more sensitive to the biological actions of D 5 . Statistical significance was also observed when this organ weight was expressed as a percentage of final body weight (Fig. 1) . Neither liver nor lung weight was increased in either sex for any group following a 14-day recovery period.
Hematology. There was little indication that D 5 exposure resulted in any biologically significant changes in hematological parameters. Within the male rats, there was no evidence of an exposure-related action of D 5 on any hematological parameter measured either at terminal necropsy (Table 2) or following a 14-day period of recovery (data not shown). In female rats in the high exposure group only, there were minor (5-6%), but statistically significant decreases observed in the numbers of RBC, Hb, and Hct following 28 days of D 3 exposure (Table  2) . These changes appeared to resolve after 14-days of nonexposure (data not shown) and were not considered to be biologically relevant in this study. All other parameters in female rats were not statistically different from control values.
Serum chemistry and urinalysis. There were no differences in urinalysis parameters or in urinary sediment microscopic analysis between D 5 -exposed or room air control animals (data not shown). There were no observed changes in serum chemistry parameters in male rats at either terminal (Table 3) or recovery necropsies (data not shown). The only observed statistically significant change in serum chemistry parameters was a 12% decrease in serum alkaline phosphatase (SAP) in the female 160 ppm exposure group (Table 3) . This decrease appears to be exposure-related (4, 5, and 12% at 25, 75, and 160 ppm, respectively) and was the only parameter observed in this study to not recover after a 14-day nonexposure period (12 and 19% decrease at 75 and 160 ppm, respectively).
Gross and histopathology. There were no Dj-related lesions observed from any of the exposure groups at terminal or recovery necropsy. The majority of gross findings were correlated to comeal mineralization or to focal or diffuse congestion in several organs. There were no microscopic treatment-related lesions in the lungs which correlated to gross observations. Additionally, histological examination of the liver did not indicate any signs of treatment-related pathology, despite the observed increase in liver weight.
Inhalation exposure to D 5 resulted in an increase in incidence and severity of goblet cell proliferation in Level 1 of the nasal cavity in both sexes at the 160 ppm concentration (Table  4 and Fig. 2B ) and an increase in incidence at 75 and 10 ppm when compared to controls ( Fig. 2A) . In neither sex was there any increase in goblet cell proliferation when compared to controls for rats exposed to 25 ppm D 5 . The incidence and severity of submucosal inflammation was increased in males (75 ppm) and females (160 ppm; Fig. 2C ). At the end of the recovery period there was still an increase in incidence of goblet cell proliferation in the high exposure group females (160 ppm). There was no incidence of submucosal inflammation in any recovery animals. Thus, it appears that the submucosal inflammation is reversible following cessation of exposure. Goblet cell proliferation appears to be not fully reversible 14 days following cessation of exposure.
In addition to the changes observed in the nasal cavity, there was also an increase in alveolar macrophage accumulation in the lung (Table 4 ). The effect was more pronounced in male than in female animals (Table 4 ) and was not observed in recovery animals. These data suggest that D 5 may induce a reversible mild pulmonary inflammatory reaction.
Humoral immunity. Rats were exposed daily for 28 days to one of five concentrations of D 5 or room air (control). On the 25th day of exposure, rats were immunized intravenously with sRBC. The humoral immune response (plaque assay) was evaluated on Day 29. There was no difference in the antibodyforming cell (AFC) response between the D 5 -exposed animals and the room air controls ( Table 5 ). Confirmation that immunosuppression could be detected by the laboratory in these assays was achieved when rats treated for 4 days prior to Rats (n = 10/sex/group) were exposed by whole body inhalation for 28 days (6 h/day, 7 days/week) to the indicated concentrations of D 3 vapor. Animals were euthanized on Day 29 after initiation of exposures. Data are presented as the mean ± SD. Blood was collected via the anterior vena cava or by cardiac puncture at the time of euthanasia and hematologic analyses performed. Data are presented as the mean ± SD. *• Statistically significant from control (0 ppm) at p £ 0.O1 as determined by Dunnett's test euthanasia with the intra-assay control material cyclophosphamide (CYP), an immunosuppressive agent, exhibited profound immunosuppression. The data were not different when expressed as AFC/spleen since there were no significant exposure-related changes in spleen size or cellularity. The antibody response to sRBC as measured in the spleen is consistent with the results obtained from the sera using an anti-sRBC ELISA (Fig. 3) .
DISCUSSION
D 5 is a member of a family of low-molecular-weight cyclic siloxanes. Siloxanes have numerous industrial, medical, military, and consumer uses. The cyclic siloxanes such as D 4 (octamethylcyclotetrasiloxane), D 5 , and D 6 (dodecamethylcyclohexasiloxane) are used primarily as intermediates in the production of polydimethylsiloxanes. They have also found use in the personal and household care industries due to their unique physical and chemical properties. D 5 is used in cosmetics and toiletries as a vehicle, an end-blocking agent in antiperspirants, and in aerosol products containing insoluble powders (Union Carbide Corporation, 1982; General Electric Company, 1991) . In addition to personal care products, exposure to D 5 and other siloxanes may come through incidental occupational exposure. For example, siloxanes have been detected in office buildings where many silicone-containing products are present (e.g., photocopiers, electronic equipment). D 5 has been measured in concentrations between 0.3 and 12.4 /xg/m 3 in these areas (Weschler, 1988) . It has also been previously measured in drinking water from selected sampling sites (Lucas, 1984) and was found in 28 of 46 composite human adipose tissue samples obtained in a national survey (Onstot et al., 1987) .
In recent years, significant interest has focused on the biocompatibility of silicones and the potential for these products to produce immunotoxic effects. This has largely been driven by the clinical literature containing case reports of adverse reactions to silicone-containing medical materials. Although the opportunity for exposure to siloxanes such as D 4 or D 5 occurs in consumer applications, it has previously been reported that these materials are safe (Cosmetic Ingredient Review, 1982 . Recently, selected silicone materials have been shown to possess humoral adjuvant activity (Nairn et al., 1995; Woolhiser etal, 1995; Klykken and White, 1996) and it has been suggested that the degree of this activity may be related to molecular size (Nairn et al., 1995) . In addition to these materials, several nonsilicone materials used in personal care products (lanolin, isopropyl palmitate, and white mineral oil) were also shown to possess humoral adjuvant activity . An adjuvant, such as Freund's complete adjuvant or the alum used in clinical vaccinations, is a material which can augment the immune response to immunogenic agents. It has been demonstrated that certain silicone fluids can act as immunological adjuvants when coadministered intramuscularly as emulsions with an antigen such as bovine serum albumin (Nairn et al., 1995; Woolhiser et al., 1995; Nicholson et al., 1996; Klykken and White, 1996; . However, when the silicone and antigen are administered separately and by different routes (e.g., subcutaneous silicone exposure and intravenous antigen challenge; Bradley et al., 1994a,b) , it appears that the adjuvant effect is lost. These studies have evaluated exposure to silicones by implantation (Bradley et al., 1994a,b) , oral gavage (KJykken and White, 1996) , and inhalation (Klykken et al.) . A variety of silicone materials have been examined in these studies, primarily focusing on the components of mammary prostheses (gel, fluid, and elastomer), but also including trace substances in these devices such as D 4 and several silicone fluids not found in the devices. As stated above, a relationship between molecular size has also been attributed to this adjuvancy effect (Nairn et al., 1995) . Because D 5 is a somewhat larger molecule than its chemical analogue, D 4 , and due to the potential for incidental human exposure to D 5 as described previously, it was of interest to determine whether inhalation exposure to this silicone material could augment (or suppress) the humoral immune response to an intravenously administered antigen, sheep erythrocytes (sRBC).
The antibody forming cell (AFC) assay is a sensitive indicator of immunological integrity, testing the ability of the host to mount an antibody response to a specific antigen. When the paniculate T-dependent antigen sRBC is used, this response requires the coordinated interaction of several different immune cells: antigen-presenting cells, T cells, and B cells. Therefore, a xenobiotic-induced effect on the functions of any of these cells can have a profound impact on the ability of B cells to produce antigen-specific antibody. D 5 administered over 28 days by vapor inhalation (0-160 ppm) produced no adverse effects (enhancement or suppression) on the IgM antibody response to sRBC, indicating that the functional activity of these cells in the humoral response is intact. This confirms the observations made by Klykken and White (1996) , Klykken et al., and Bradley et al. (1994a,b) and indicates that the humoral adjuvancy of silicones observed in previous studies is likely the result of the conditions of experimental exposure (coadministration of an emulsion).
During method development for the present study, 160 ppm was determined to be the maximal reproducibly attainable D 5 vapor concentration which contained no aerosol. D 5 is a volatile silicone fluid and thus a substantial portion of the administered material may have been eliminated from the lung before it could be taken up into the bloodstream and distributed systemically. That is, D 5 may be deposited and adsorb in the lung but may not be readily absorbed and thus could be eliminated in the expired air as parent compound. It should be noted, however, that exposure-related changes in liver weight were observed at 160 ppm, indicating that a biologically relevant concentration of D 5 was absorbed. Thus it appears that inhalation exposure to D 5 does not alter humoral immunity.
Interestingly, at the end of the recovery period, in male rats only there was an increase in spleen weight observed at 25 and 75 ppm which was not observed in the high exposure group. This increase was not observed for any exposure group at terminal necropsy. In addition, in a 90-day study with D 3 which included a recovery period, no changes were observed in either male or female spleen weights at the end of recovery (Burns-Naas et al., 1998) . In addition to the fact that the observation occurred in the intermediate concentrations only, " Rats (n = 10/group) were exposed by whole body inhalation for 28 days (6 h/day, 7 days/week) to the indicated concentrations of D, vapor. Data in parentheses are the incidence observed at the end of the 14-day recovery period. Data are presented as the incidence per total number of animals examined.
this supports the conclusion that the effect observed in male rats in this study may not be toxicologically relevant.
As with a similar study with D 4 (Klykken et al) , there was little indication that D 3 exposure resulted in any biologically significant changes in hematological parameters. The only observed hematological changes were in female rats in the high exposure group. In that group, there were minor (5-6%), but statistically significant, decreases observed in the numbers of RBC, Hb, and Hct following 28 days of D 5 exposure. These changes appeared to resolve themselves after 14-days of nonexposure and were not considered to be biologically relevant in this study. Similar investigations following 1-and 3-month (Burns-Naas et al, 1998), exposures to D 5 have also demonstrated small changes in the erythroid compartment, but none of these observations are consistent between these three studies or even within a single sex. This further supports the hypothesis that the observed alterations in hematology may not be toxicologically important.
The only observed statistically significant change in serum chemistry parameters was a 12% decrease in serum alkaline phosphatase (SAP) in the female 160 ppm exposure group. This decrease appears to be exposure-related and was the only parameter observed in this study to not recover after a 14-day nonexposure period. This observation with SAP is similar to that observed for D 4 in a similar investigation (14% decrease at 540 ppm; Klykken et al.) . Because an indicator of hepatic toxicity is usually taken to be an increase in SAP, these observations may not be biologically relevant.
In this study, the most notable outcomes of D 5 exposure were reversible increases in liver weight (Table 1) and liverto-body weight ratios (male and female, 160 ppm; Fig. 1 ) and apparent exposure-related actions on increase in Level 1 nasal goblet cell proliferation. Whether the increase in liver weight observed at the end of 28 days of exposure is due to hypertrophy, hyperplasia, or a combination of both is not known at this time. Histopathological examination did not clearly support either and studies are currently in progress to specifically address this issue. Further experiments confirm the observed increase in liver size and have also demonstrated the exposurerelated induction of cytochrome P450 enzymes (McKim et al., 1996; McKim et al., 1997) . The apparent reversibility of hepatomegaly upon cessation of exposure to D 5 and the results of the P450 analyses suggest that this may be an adaptive response. It should be noted here that in a similar study with D 4 , an increase in both liver weight and liver-to-body weight ratio was also observed (Klykken et ai) . In those studies, female rats also appeared to be more sensitive to this effect and in both male and female animals the increase was reversible upon cessation of exposure. Also, the vapor concentrations of D 4 which produced statistically significant increases in liver weight (20 ppm, females) were significantly lower than that of D 5 required to produce similar effects in this investigation (160 ppm, females). This suggests that there may be a relationship between the observed actions of these two molecules and their relative molecular sizes or some other physio-chemical parameter.
Following a 28-day inhalation exposure, there was a slight increase in incidence of pulmonary alveolar macrophage infiltration and interstitial inflammation observed in the lungs of rats exposed to 160 ppm D 5 which is suggestive of a low level inflammatory reaction. This effect appeared to be reversible, with no evidence of immune cell activity at the end of the 14-day recovery period. Similar observations were noted for 28-day inhalation exposure to D 4 (Klykken et al) " Animals were exposed by whole body inhalation for 28 days (6 h/day, 7 days/week) to the indicated concentrations of D 3 vapor. Cyclophosphamide was administered daily by i.p. injection (25 mg/kg) on days 24-28 of exposure. Animals were euthanized on the 29th day after initiation of exposures and the plaque assay performed within 24 h after euthanasia. Data are presented as the mean ± SE.
* Significantly different from control (0 ppm) at p < 0.05 as determined by Dunnett's test. ** Significantly different from control (0 ppm) at p £ 0.01 as determined by Dunnett's test.
period of time or it may lead to a more pronounced respiratory condition. It is well-known that alveolar macrophages can play a central role in the development of inflammation and fibrosis and are capable of producing a variety of bioactive cytokines and chemoattractants which influence the activities of other inflammatory and immune cells. There is good evidence with inhaled paniculate and aerosol materials that cell proliferation, Anti-sRBC serum titer of immunized rats following inhalation exposure to D 5 . Fisher 344 rats (n = 10) were exposed 6 h/day, 7 days/week for 28 days to the indicated concentrations of D 3 vapor. Positive control animals (n = 5) were administered cyclophosphamide (CYP; 25 mg/kg) by i.p. injection on Days 24-28. All rats were immunized i.v. with 2 X 10 s sRBC on Day 25. At the time of euthanasia (Day 29), blood was collected from the vena cava and sera prepared for analysis. Sera were shipped on dry ice to the Medical College of Virginia for anti-sRBC ELISA analysis. "Statistically different from the room air control (0 ppm) at p s 0.01 as determined by a Student t test. fibrotic foci, and chronic disease occur in a dose-related manner in rats with long-term exposure to these types of materials (Gordon and Amdur, 1991; Witschi and Last, 1996) . However, the evidence for this type of effect and subsequent specific toxic progression is much less well-defined following prolonged inhalation of vapors. In fact, an influx of some inflammatory cells is a common occurrence with materials which produce primary or secondary irritancy effects (Gordon and Amdur, 1991; Witschi and Last, 1996) .
It is unknown whether the observed increase in lung weight in male rats represents a biologically significant finding in this study, since it occurs in males only and the histopathological findings were noted in both sexes. Additionally, this increase was not present at recovery. An increase in lung weight has previously been observed in both sexes following 1-and 3-month nose-only inhalation of D 5 and in those studies appeared to be related to exposure (Bums-Naas etaL, 1998) . Importantly, however, the exposure concentrations of D 5 at which those observations were made (224 ppm) were those which exposed rats to a mixed aerosol/vapor. At lower concentrations (26-86 ppm), no changes in lung weight were observed Because of the minimal pulmonary changes and their reversibility, it is likely that the tissue changes observed in the lung following D 5 exposure represent a low-level irritative response to prolonged (6 h/day, 7 days/ week) daily vapor inhalation.
Inhalation exposure to D 5 resulted in an increase in incidence and severity of goblet cell proliferation in Level 1 of the nasal cavity in both sexes (160 ppm) and an increase in incidence at 75 and 10 ppm. In neither sex was there any increase in goblet cell proliferation when compared to controls at Pennsylvania State University on February 23, 2013 http://toxsci.oxfordjournals.org/ Downloaded from for rats exposed to 25 ppm D 5 . The incidence and severity of submucosal inflammation was increased in males (75 ppm) and females (160 ppm). At the end of the recovery period there was increased incidence of goblet cell proliferation only in the high exposure females (160 ppm). Submucosal inflammation was not observed in any recovery animals. Thus, it appears that the goblet cell proliferation is not fully reversible 14 days following cessation of exposure. Nasal goblet cell proliferation is frequently observed following repeated exposure to materials producing irritation effects (Boorman et al., 1990; National Toxicology Program Pre-Chronic Database, 1996) . The degree of irritation, sensitivity of the mucosal surface, and the integrity of the cilia often determine the course of the toxic response. If the irritant is very mild and the exposure duration is short, goblet cell hyperplasia may be the only response (Boorman et al., 1990) . Although goblet cell proliferation was observed in the present study and may have the same etiology as the low-level inflammatory response observed in the lung, D 5 inhalation exposure did not produce other histopathological changes characteristic of classical, more severe, respiratory irritants: deciliation, epithelial cell degeneration, squamous metaplasia, olfactory epithelium lesions, and frank necrosis (Jiang et al, 1986) .
In conclusion, exposure to D 5 via vapor inhalation (10-160 ppm) did not alter the humoral immune response (either suppression or enhancement), indicating that D 5 is neither immunosuppressive nor acting as a humoral adjuvant under the conditions employed in this experiment. There seemed to be a sex-related difference in observed endpoints, as females appeared to be more sensitive to exposure-related minor alterations in several toxicological parameters. Exposure-related increases in liver weights were observed at terminal necropsy. The results of serum chemistry analysis, organ weight measurements, and histopathological examination suggest that this slight increase in liver weight may not be toxicologically or biologically significant. Thus, the no observed adverse effect level (NOAEL) for systemic toxicity (based primarily on the changes observed in liver weights) was 75 ppm, a value above the current 10 ppm industrial hygiene guide for daily occupational exposure to D 5 . Finally, histopathological evidence indicates the primary target organ following D 5 inhalation exposure is the respiratory tract, with minimal inflammatory cell infiltration and interstitial inflammation, as well as goblet cell proliferation in the anterior nasal passages. Fourteen days following cessation of exposure, morphological alterations (excluding goblet cell proliferation) were found to be reversible, as were organ weight alterations. These data suggest that high concentration D 5 vapor inhalation provokes a minor reversible pulmonary inflammatory response.
